FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a compound selected from compounds represented by the structural formulas (I), (II), (III), (IV), (V), (VI), or to a pharmacologically acceptable salt thereof. The invention also relates to a pharmaceutical composition exhibiting an activating effect with respect to cholinergic neurons and/or a neuroprotective effect, based on the described compounds.
EFFECT: technical result is production of new compounds and a pharmaceutical composition based thereon applicable in medicine for treating Alzheimer's disease, dementia with Lewy bodies, and Parkinson's disease with dementia.
17 cl, 6 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PENTACYCLIC COMPOUND SALT AND CRYSTAL THEREOF | 2020 |
|
RU2820938C2 |
| PENTACYCLIC HETEROCYCLIC COMPOUND | 2020 |
|
RU2815382C2 |
| PYRIMIDINE DERIVATIVES USED AS PROTEIN KINASE INHIBITORS | 2008 |
|
RU2478100C2 |
| PYRAZOLE DERIVATIVES APPLIED AS PROTEIN KINASE INHIBITORS | 2013 |
|
RU2623221C2 |
| DIHYDRODIAZEPINES USEFUL AS INHIBITORS OF PROTEIN KINASE | 2007 |
|
RU2475488C2 |
| CONDENSED ISOINDOLONES AS INHIBITORS OF PROTEIN KINASE C | 1996 |
|
RU2191175C2 |
| PIPERAZINO[1,2-A]INDOLE-1-ONES AND [1,4] DIAZEPTINO[1,2-A]INDOLE-1-ONE | 2014 |
|
RU2628126C2 |
| TRIAZOLO (4,3-a) 1,4 BENZO DIAZEPINES AND THRENO (3,2 | 1992 |
|
RU2094436C1 |
| METHOD OF OBTAINING BENZO[b][1,4]DIAZEPINE-2,4-DIONE DERIVATIVE | 2010 |
|
RU2553676C2 |
| PYRIDINYLPYRAZOLOQUINOLINE COMPOUNDS | 2014 |
|
RU2655172C2 |
